HPLC analysis, isolation and identification of a new degradation product in carvedilol tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 1, 2008, Pages 70-77

  Galanopoulou, Olga ^a   Rozou, Stavroula ^b   Antoniadou Vyza, Ekaterini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ELPEN Pharmaceutical Co Inc   (Greece)

Author keywords

Carvedilol; HPLC; Moisture; NMR; PVP; Stability; Tablets

Indexed keywords

ACETONITRILE; CARVEDILOL; PHOSPHATE BUFFERED SALINE; POVIDONE;

ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TABLET;

ACETONITRILES; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; BUFFERS; CALIBRATION; CARBAZOLES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GUIDELINES AS TOPIC; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; PHOSPHATES; POVIDONE; PROPANOLAMINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS; WATER;

EID: 49949095971     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.05.004     Document Type: Article

References (21)

1. Karle C.A., Kreye V.A.W., Thomas D., Röckl K., Kathöfer S., Zhang W., and Kiehn J. Cardiovasc. Res. 49 (2001) 361-370
2. Chen J.J., and Shih N.L. Acta Cardiol. Sin. 19 (2003) 93-94
3. Franciosa J.A., Massie B.M., Lukas M.A., Nelson J.J., Lottes S., Abraham W.T., Fowler M., Gilbert E.M., Greenberg B., and for the COHERE Participant Physicians. Am. Heart J. 148 (2004) 4718-4726
4. Stoschitzky K., Koshucharova G., Lercher P., Maier R., Sakotnik A., Klein W., Liebmann P.M., and Lindner W. Chirality 13 (2001) 7342-7346
5. ICH Topic Q3B(R2), Impurities in New Drug Products (1999), (CPMP/ICH/2738/99, http://www.ich.org/LOB/media/MEDIA421.pdf).
6. ICH Topic Q1A(R2), Stability Testing of New Drug Substances and Products (1999), (CPMP/ICH/2736/99, http://www.ich.org/LOB/media/MEDIA419.pdf).
7. ICH Topic Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (1996), (CPMP/ICH/367/96, http://www.ich.org/LOB/media/MEDIA430.pdf).
8. Ptáek P., Macek J., and Klíma J. J. Chromatogr. B 789 (2003) 405-410
9. Zarghi A., Foroutan S.M., Shafaati A., and Khoddam A. J. Pharm. Biomed. Anal. 44 (2007) 250-253
10. Jeong D.W., Kim Y.H., Ji H.Y., Youn Y.S., Lee K.C., and Lee H.S. J. Pharm. Biomed. Anal. 44 (2007) 547-552
11. Machida M., Watanabe M., Takechi S., Kakinoki S., and Nomura A. J. Chromatogr. B 798 (2003) 187-191
12. Yang E., Wang S., Kratz J., and Cyronak M.J. J. Pharm. Biomed. Anal. 36 (2004) 609-615
13. Wang S., Cyronak M., and Yang E. J. Pharm. Biomed. Anal. 43 (2007) 701-707
14. Sazonov V.P., and Shaw D.G. J. Phys. Chem. Ref. Data 31 (2002) 989-1133
15. Gu T., Gu Y., Zheng Y., Wiehl P.E., and Kopchick J.J. Sep. Technol. 4 (1994) 258-260
16. Pence D.N., and Gu T. Sep. Technol. 6 (1996) 261-264
17. Cheng H.Y., Randall C.S., Holl W.W., Constantinides P.P., Yue T.L., and Feuerstein G.Z. Biochim. Biophys. Acta-Biomembr. 1284 (1996) 20-28
18. Marques M.P.M., Oliveira P.J., Moreno A.J.M., and Batista de Carvalho L. J. Raman Spectrosc. 33 (2002) 778-783
19. Xiang T.X., and Anderson B.D. Pharm. Res. 22 (2005) 1205-1214
20. Almeida D.R.P.B., Gasparro D.M., Martinek T.A., Fülöp F., and Csizmadia I.G. J. Phys. Chem. A 108 (2004) 7719-7729
21. Fields J.D., and Kropp P.J. J. Org. Chem. 65 (2000) 5937-5941